Synthetic Biology
Maturity
2 / 5
Basis, source, vintage
Commercial in specific ingredients and materials; broader engineering of organisms remains research-stage. Design accelerating faster than scale-up.
Source: E-143 (NASEM, The Age of AI in the Life Sciences, 23 Apr 2025); WKO Innovation Map (2025–2026)
What it is
Designing and building biological systems that do not exist in nature — engineered organisms, synthetic chromosomes and designed proteins.
What it does
It treats biology as a manufacturing platform. Where it works, it substitutes biological production for chemical or extractive production, which changes supply chains rather than efficiency.
Common misconception
That it is an extension of gene editing. Editing modifies what exists; this builds what does not, and the design, biosecurity and scale-up questions are correspondingly different.
Steepens
- Circular Economy and Materials Substitution — moderate
- Food System Transformation — moderate
- Zoonotic and Antimicrobial Resistance Risk — moderate · ○ shared candidate constraint (with 1 others)
- Critical Mineral and Resource Scarcity — marginal · marginal: not counted in the minimum
What would change its gradient
- Fermentation scale-up capacity, which is a capital-intensive bottleneck
- Biosecurity governance keeping pace with diffusing capability
- Feedstock cost, which determines whether biological production competes
Shares megatrends with
- 3D Printing & Additive Manufacturing
- Alternative Proteins & Precision Fermentation
- Biomaterials & Biofabrication
- BioTech & Genomics
- Consumption Norms
- Gene Editing
In the book
Why the Future Arrives Unevenly — Ch. 9 — The Closing of the Planetary Envelope · Ch. 12 — Reading the Ramp · Ch. 14 — How Hype Is Manufactured
Sources
- Commercial in specific ingredients and materials; broader engineering of organisms remains research-stage. Design accelerating faster than scale-up. Source: E-143 (NASEM, The Age of AI in the Life Sciences, 23 Apr 2025); WKO Innovation Map (2025–2026).